Scientists develop risk score to forecast bronchiectasis attacks

NCT ID NCT07599839

Recruiting now Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is creating a new scoring system called BASE to measure how severe bronchiectasis is and predict the chance of a flare-up over the next year. Researchers will follow 750 adults with non-cystic fibrosis bronchiectasis for 12 months, collecting routine medical data. No new treatments are being tested; the goal is to give doctors a better way to identify high-risk patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple, objective tool for doctors to better predict which patients are at risk of worsening and tailor monitoring or treatment.
What could go wrong: This is an observational study, not a treatment trial. The tool may not prove accurate enough in practice, and results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchiectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRONCHIECTASIS BRONCHIECTASIS WITH ACUTE EXACERBATION NON-CYSTIC FIBROSIS BRONCHIECTASIS

Contacts and locations

Locations

Assiut university-Faculty of Medicine
RECRUITING

Asyut, Asyut Egypt, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.